KEDRION BIOPHARMA secures contract for Invitation To Submit Proposals Under The Agreement S -2023 438 - Derivatives Of Human Plasma 2023 671 - Miscellaneous Medicines And 2025 1589 - Miscellaneous Medicines For The Acquisition Of Medicines

Portugal, April 8 -- Portugal based KEDRION BIOPHARMA has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Invitation To Submit Proposals Under The Agreement S -2023 438 - Derivatives Of Human Plasma 2023 671 - Miscellaneous Medicines And 2025 1589 - Miscellaneous Medicines For The Acquisition Of Medicines. The value of the contract is worth 56700 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....